COVID-19 update: FDA provides update on inspection plans

The U.S. Food and Drug Administration (FDA) recently provided an update regarding its plans for conducting routine surveillance inspections of domestic and foreign facilities during the COVID-19 pandemic.

FDA announced in March that it would temporarily postpone foreign and domestic inspections, with the exception of certain "mission-critical" inspections, as identified on a case-by-case basis. In its most recent update, FDA Commissioner Stephen Hahn M.D. stated that the agency's current approach will continue as local, national, and international conditions warrant.

Read More: COVID-19 update: FDA provides update on inspection plans


Download PDF Back To Listing
Loading data